Toronto - Delayed Quote CAD

Cipher Pharmaceuticals Inc. (CPH.TO)

8.50 -0.30 (-3.41%)
At close: April 19 at 3:59 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
21,162.00
21,162.00
20,675.00
21,943.00
21,607.00
Cost of Revenue
4,069.00
4,069.00
3,992.00
3,684.00
3,057.00
Gross Profit
17,093.00
17,093.00
16,683.00
18,259.00
18,550.00
Operating Expense
7,060.00
7,060.00
5,633.00
5,200.00
6,386.00
Operating Income
10,033.00
10,033.00
11,050.00
13,059.00
12,164.00
Net Non Operating Interest Income Expense
1,870.00
1,870.00
464.00
-80.00
-291.00
Other Income Expense
778.00
778.00
-35.00
-1,920.00
-5,337.00
Pretax Income
12,681.00
12,681.00
11,479.00
11,059.00
6,536.00
Tax Provision
-7,702.00
-7,702.00
-15,157.00
3,301.00
2,150.00
Net Income Common Stockholders
20,383.00
20,383.00
26,636.00
7,758.00
4,549.00
Diluted NI Available to Com Stockholders
20,383.00
20,383.00
26,636.00
7,758.00
4,549.00
Basic EPS
1.28
0.82
1.05
0.29
0.17
Diluted EPS
1.26
0.80
1.03
0.29
0.17
Basic Average Shares
25,219.73
25,004.84
25,376.29
26,597.84
27,025.03
Diluted Average Shares
25,611.33
25,422.20
25,799.16
26,830.02
27,365.12
Total Expenses
11,129.00
11,129.00
9,625.00
8,884.00
9,443.00
Net Income from Continuing & Discontinued Operation
20,383.00
20,383.00
26,636.00
7,758.00
4,549.00
Normalized Income
19,916.20
19,916.20
26,661.83
9,104.90
7,967.41
Interest Income
1,870.00
1,870.00
464.00
12.00
32.00
Interest Expense
--
--
--
92.00
323.00
Net Interest Income
1,870.00
1,870.00
464.00
-80.00
-291.00
EBIT
10,033.00
10,033.00
11,050.00
13,059.00
6,859.00
EBITDA
11,260.00
11,260.00
12,039.00
13,760.00
8,064.00
Reconciled Cost of Revenue
4,069.00
4,069.00
3,992.00
3,684.00
3,057.00
Reconciled Depreciation
1,227.00
1,227.00
989.00
701.00
1,205.00
Net Income from Continuing Operation Net Minority Interest
20,383.00
20,383.00
26,636.00
7,758.00
4,386.00
Total Unusual Items Excluding Goodwill
778.00
778.00
-35.00
-1,920.00
-5,337.00
Total Unusual Items
778.00
778.00
-35.00
-1,920.00
-5,337.00
Normalized EBITDA
10,482.00
10,482.00
12,074.00
15,680.00
13,401.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
311.20
311.20
-9.17
-573.10
-1,755.59
12/31/2020 - 5/7/2004
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

MOB.ST Moberg Pharma AB (publ)
30.72
+13.11%
 
MDP.TO Medexus Pharmaceuticals Inc.
1.6500
+6.45%
 
GRIN.CN Grown Rogue International Inc.
0.8800
-4.35%
 
CANB.V CanadaBis Capital Inc.
0.0800
-5.88%
 
CRDL.TO Cardiol Therapeutics Inc.
2.4700
+5.56%
 
GUD.TO Knight Therapeutics Inc.
5.72
-1.21%
 
RX.V BioSyent Inc.
8.50
+0.59%
 
HLS.TO HLS Therapeutics Inc.
4.9500
+0.61%
 
HASH.V SIMPLY SOLVENTLESS CONCENTRATES
0.2150
-15.69%
 
VPH.TO Valeo Pharma Inc.
0.1200
-22.58%